Chemclin Diagnostics Company Description

Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic reagents and instruments.

Its products include LiCAA series of diagnostic reagents based on photo-induced chemiluminescence and CC series based on enzymatic chemiluminescence diagnostic reagents and instruments, primarily used for infectious diseases, such as hepatitis B, hepatitis C, AIDS, syphilis, hepatitis A, hepatitis E, etc.; and detection of tumor markers, thyroid hormones, reproductive endocrine hormones, cardiac markers, and inflammation.

The company was founded in 2007 and is headquartered in Beijing, China.

Chemclin Diagnostics Co., Ltd.

Country	China
Founded	2007
Industry	Diagnostics & Research
Sector	Healthcare
Employees	731

Contact Details

Address: Incubator Building, 1st and 6th Floors Beijing, 100094 China
Phone	86 06 5871 7511
Website	chemclin.com

Stock Details

Ticker Symbol	688468
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100005311
SIC Code	3845

Key Executives

Name	Position
Yanling Huang	Chief Financial Officer, Secretary and Director